Les patients avec indice de performance supérieur à 1

Many decision algorithms based on randomized trials are the basis of treatments proposed for patients with bronchial cancer. Nevertheless, in most of these trials, the number of patients with an altered performance status is limited or absent. The aim of this article is to present the performance status scales and their reproducibility, the prognostic role of this performance status and to review the existing literature on the therapeutic management of patients with lung cancer and an altered performance status.